概括
血小板中SEC61B的升高会增加的泄漏,导致过度反应和糖尿病时动脉血栓形成的风险. 针对这种途径可以预防慢性疾病中的血栓.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 血小板过敏反应与慢性炎症疾病中的动脉血栓形成有关.
- 了解驱动血小板功能障碍的分子机制对于预防血栓形成至关重要.
研究的目的:
- 为了确定与糖尿病中血小板过敏反应相关的分子标.
- 研究SEC61B在血小板平衡和反应性中的作用.
主要方法:
- 来自糖尿病患者和高血糖小鼠的血小板的无偏的蛋白质组分析.
- 评估SEC61B表达及其对内细胞网膜 (ER) 泄漏的影响.
- 对SEC61B调制的血小板反应性和血栓形成的评估.
主要成果:
- 在糖尿病和高血糖患者的血小板中发现了升高的SEC61B表达.
- 增加的SEC61B促进了ER的泄漏,提高了基底细胞质水平.
- 通过SEC61B介导的失调导致了血小板过度反应,并影响了体内血栓形成.
结论:
- 通过ER泄漏,SEC61B是糖尿病中血小板过敏反应的关键调解者.
- 在糖尿病患者中,SEC61B代表了预防动脉血栓形成的潜在治疗标.
- 通过SEC61B通路调节平衡,为血栓形成治疗提供了一种新的策略.
相关概念视频
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Structure and Function of Platelets
1.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
Inflammation
55.1K
Overview
55.1K
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K


